Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Oct 15 - Oct 20
Akoumianakis I et al
Development 119(1):7184
Drug treatments were added in KRB (25 mM glucose) (1 hr, 37 C, 5% CO 2 )
Patient Assessment Protocol Comprehensive medical history with obesity-specific screening Physical examination including BMI, waist circumference, and body composition analysis Laboratory workup: complete metabolic panel, lipid panel, HbA1c, thyroid function, insulin levels Screening for sleep apnea, PCOS, Cushing syndrome, and other secondary causes of obesity Mental health screening for binge eating disorder and depression Readiness-to-change assessment Medication Formulary for Your Medical Weight Loss Program GLP-1 receptor agonists: Semaglutide (Wegovy), liraglutide (Saxenda), tirzepatide (Zepbound) Sympathomimetic agents: Phentermine (short-term), phentermine/topiramate (Qsymia) Other FDA-approved options: Naltrexone/bupropion (Contrave), orlistat (Xenical/Alli) Off-label considerations: Metformin, topiramate, bupropion (when clinically appropriate and properly documented) Your medical weight loss program's protocols should specify prescribing criteria, dosing escalation schedules, monitoring requirements, and discontinuation criteria for each medication
Tirzepatide results were even more impressive, with some participants losing over 20% of their body weight
The administration of the GHRH analog at night resulted in a rapid increase in growth hormone levels within 10 minutes, which was sustained for up to 2 hours
US$ 27.37
US$ 20.11
US$ 21.88
US$ 27.96
US$ 26.00
US$ 23.39
US$ 20.28
US$ 28.47
